Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)

Clinical trial NCT00750919 · TERMINATED

Trial details

NCT number: NCT00750919
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Sleep Initiation and Maintenance Disorders Mental Disorders Dyssomnias Sleep Disorders Sleep Disorders, Intrinsic

Start date: 2008-10-07
Primary completion: 2010-03-10
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.